United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$233.85 USD
-2.10 (-0.89%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $233.96 +0.11 (0.05%) 6:22 PM ET
3-Hold of 5 3
B Value F Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (89 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.52 | 9.99 |
Current Quarter Estimate | 5.63 | -2.04 | 60.00 |
Year Ago Quarter Estimate | 4.86 | -0.59 | 52.54 |
Next Quarter Estimate | 5.86 | -2.00 | 61.00 |
Next Year Estimate | 24.51 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 18.43 | 10.40 | 17.08 |
Next Year | 4.48 | 13.10 | 8.00 |
Last 5 Years | 21.80 | 5.50 | 8.10 |
Next 5 Years | NA | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 11.89 | -5.88 |
Price/Book (MRQ) | 1.85 | 1.73 |
Price/Cash Flow (MRFY) | 10.68 | 8.52 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 42.31% | -19.76% |
Return on Equity (TTM) | 17.72% | -75.03% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.